Citation Impact
Citing Papers
Meta‐analysis: esomeprazole or rabeprazole vs. first‐generation pump inhibitors in the treatment of H elicobacter pylori infection
2012
Review article: the global emergence of Helicobacter pylori antibiotic resistance
2015
Drugs plus ligation to prevent rebleeding in cirrhosis: an updated systematic review
2013
Rifaximin treatment is associated with reduced risk of cirrhotic complications and prolonged overall survival in patients experiencing hepatic encephalopathy
2017
Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol
2012
The IASP classification of chronic pain for ICD-11: chronic primary pain
2018 Standout
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report
2016 Standout
Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report
2012 Standout
UK guidelines on the management of variceal haemorrhage in cirrhotic patients
2015
Improving prognosis following a first variceal haemorrhage over four decades
2001
A randomized trial to assess whether portal pressure guided therapy to prevent variceal rebleeding improves survival in cirrhosis
2017
Guidelines for the welfare and use of animals in cancer research
2010 Standout
Reductions in 28-Day Mortality Following Hospital Admission for Upper Gastrointestinal Hemorrhage
2011 Standout
Randomized, controlled trial of carvedilol versus nadolol plus isosorbide mononitrate for the prevention of variceal rebleeding
2012
Empirical levofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: a randomised trial
2010
A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis C
2003 Standout
Cytokines in inflammatory bowel disease
2014 Standout
“Rescue” regimens after Helicobacter pylori treatment failure
2008
Polymerase chain reaction: A sensitive method for detectingHelicobacter pyloriinfection in bleeding peptic ulcers
2005
Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: A randomized, controlled, double-blind trial
2002
Randomised clinical trial comparing sequential and concomitant therapies for Helicobacter pylori eradication in routine clinical practice
2013
Antibiotic resistance and CYP2C19 polymorphisms affect the efficacy of concomitant therapies forHelicobacter pyloriinfection: an open-label, randomized, single-centre clinical trial
2016
Global burden of cancers attributable to infections in 2008: a review and synthetic analysis
2012 Standout
The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults
2016
Five-year sequential changes in secondary antibiotic resistance ofHelicobacter pyloriin Taiwan
2015
Changes of Intestinal Functions in Liver Cirrhosis
2016 Standout
Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials
2014
The Intriguing Relationship of <i>Helicobacter pylori</i> Infection and Acid Secretion in Peptic Ulcer Disease and Gastric Cancer
2011
Endoscopic Therapy for Bleeding Ulcers: An Evidence-Based Approach Based on Meta-Analyses of Randomized Controlled Trials
2008
Double‐Dose, New‐Generation Proton Pump Inhibitors Do Not Improve Helicobacter pylori Eradication Rate
2007
Treatment of gastropathy and gastric antral vascular ectasia in patients with portal hypertension
2007
Review article: 13C‐urea breath test in the diagnosis of Helicobacter pylori infection – a critical review
2004
Transfusion Strategies for Acute Upper Gastrointestinal Bleeding
2013 Standout
Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium
2007 StandoutNobel
Efficacy of Probiotic Supplementation Therapy for Helicobacter pylori Eradication: A Meta-Analysis of Randomized Controlled Trials
2016
Association of interleukin‐1 gene polymorphisms with gastric cancer: A meta‐analysis
2006
Efficacy of tailoredHelicobacter pylorieradication therapy based on antibiotic susceptibility andCYP2C19genotype
2014
Attempts to enhance the eradication rate ofHelicobacter pyloriinfection
2014
Levofloxacin, bismuth, amoxicillin and esomeprazole as second-line Helicobacter pylori therapy after failure of non-bismuth quadruple therapy
2016
A Pilot Randomized Controlled Study of Dexlansoprazole MR-Based Triple Therapy for Helicobacter Pylori Infection
2016
Hybridvssequential therapy for eradication ofHelicobacter pyloriin Taiwan: A prospective randomized trial
2015
Randomized controlled study of 3 different types of hemoclips for hemostasis of bleeding canine acute gastric ulcers
2006
Proton Pump Inhibitor Therapy for Peptic Ulcer Bleeding: Cochrane Collaboration Meta-analysis of Randomized Controlled Trials
2007
A Comparative Study of Sequential Therapy and Standard Triple Therapy for Helicobacter pylori Infection: A Randomized Multicenter Trial
2014
Kyoto global consensus report onHelicobacter pylorigastritis
2015 Standout
Prospective multi-region study on primary antibiotic resistance of Helicobacter pylori strains isolated from Chinese patients
2014
Concomitant, sequential, and hybrid therapy for H. pylori eradication: A pilot study
2013
Value of the Hepatic Venous Pressure Gradient to Monitor Drug Therapy for Portal Hypertension: A Meta-Analysis
2007
Third-Line Rescue Therapy with Bismuth-Containing Quadruple Regimen After Failure of Two Treatments (with Clarithromycin and Levofloxacin) for H. pylori Infection
2013
Wait-and-see policy or laparoscopic cholecystectomy after endoscopic sphincterotomy for bile-duct stones: a randomised trial
2002
Urgent vs. elective endoscopy for acute non-variceal upper-GI bleeding: an effectiveness study
2004
When to discharge patients with bleeding peptic ulcers: a prospective study of residual risk of rebleeding
1996
Comparative Study of Helicobacter pylori Eradication Rates With 5-day Quadruple “Concomitant” Therapy and 7-day Standard Triple Therapy
2012
Portal Hypertensive Gastropathy and Colopathy
2014
Smoking Increases the Treatment Failure for Helicobacter pylori Eradication
2006
Vascular disorders of the liver # †
2008 Standout
Global cancer transitions according to the Human Development Index (2008–2030): a population-based study
2012 Standout
ACG Clinical Guidelines: Diagnosis and Management of Celiac Disease
2013 Standout
American Gastroenterological Association Technical Review on the Evaluation of Dyspepsia
2005
The multiple uses of fluorescent proteins to visualize cancer in vivo
2005
The response of Asian patients with functional dyspepsia to eradication of Helicobacter pylori infection
2009
Role of the Microbiota in Immunity and Inflammation
2014 Standout
The Natural History of Portal Hypertensive Gastropathy in Patients with Liver Cirrhosis and Mild Portal Hypertension
2004
Empirical modified sequential therapy containing levofloxacin and high-dose esomeprazole in second-line therapy for Helicobacter pylori infection: a multicentre clinical trial
2011
Dual Therapy Versus Monotherapy in the Endoscopic Treatment of High-Risk Bleeding Ulcers: A Meta-Analysis of Controlled Trials
2007
Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis
2007
Portal hypertensive bleeding in cirrhosis
2016 Standout
Should We Still Subcategorize -Associated Dyspepsia as Functional Disease?
2011
Helicobacter pylori eradication versus prokinetics in the treatment of functional dyspepsia: a randomized, double-blind study
2006
Endoscopic hemostasis in peptic ulcer bleeding for patients with high-risk lesions: a series of meta-analyses
2009
Hyperoncotic colloids and acute kidney injury: a meta-analysis of randomized trials
2010
Functional Dyspepsia Impacts Absenteeism and Direct and Indirect Costs
2010
Nonbismuth Quadruple (Concomitant) Therapy: Empirical and Tailored Efficacy versus Standard Triple Therapy for Clarithromycin‐Susceptible Helicobacter pylori and versus Sequential Therapy for Clarithromycin‐Resistant Strains
2012
Helicobacter pylori treatment in the era of increasing antibiotic resistance
2010
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
2013 Standout
Ligands working as receptors: reverse signaling by members of the TNF superfamily enhance the plasticity of the immune system
2004
Host factors are important in determining clinical outcomes of Helicobacter pylori infection
2006
The Impact of the Gut Microbiota on Human Health: An Integrative View
2012 Standout
Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy
2013
The role of Helicobacter pylori infection in the web of gastric cancer causation
2011
Factors Affecting First-Line Triple Therapy of Helicobacter pylori Including CYP2C19 Genotype and Antibiotic Resistance
2014
Review article: non-bismuth quadruple (concomitant) therapy for eradication of Helicobater pylori
2011
Helicobacter pyloritherapy: Present and future
2012
Molecular mechanisms of T cell co-stimulation and co-inhibition
2013 Standout
Rational Helicobacter pylori Therapy: Evidence-Based Medicine Rather Than Medicine-Based Evidence
2013
A pilot project examining the predicted preferences of patients and physicians in the primary prophylaxis of variceal hemorrhage
2007
Genomic analysis identifies association of Fusobacterium with colorectal carcinoma
2011 Standout
Prevalence of Antibiotic Resistance in Helicobacter pylori: A Systematic Review and Meta-analysis in World Health Organization Regions
2018 Standout
Management of Patients With Ulcer Bleeding
2012 Standout
Coadaptation of Helicobacter pylori and humans: ancient history, modern implications
2009
Multicentre randomised controlled study comparing carvedilol with variceal band ligation in the prevention of variceal rebleeding
2014
Helicobacter pylori: perspectives and time trends
2014
Assessment of Sequential and Standard Triple Therapy in Treatment of Helicobacter pylori Infection in Children Dependent on Bacteria Sensitivity to Antibiotics
2016
Albumin: Pathophysiologic basis of its role in the treatment of cirrhosis and its complications
2013
Randomized clinical trial comparing ten day concomitant and sequential therapies for Helicobacter pylori eradication in a high clarithromycin resistance area
2016
Review article: the modern management of portal hypertension – primary and secondary prophylaxis of variceal bleeding in cirrhotic patients
2008
Gastric cancer
2020 Standout
Efficacy and Safety of Quinolone-Containing Rescue Therapies After the Failure of Non-Bismuth Quadruple Treatments for Helicobacter pylori Eradication: Systematic Review and Meta-Analysis
2017
Endoscopic clipping versus injection and thermo-coagulation in the treatment of non-variceal upper gastrointestinal bleeding: a meta-analysis
2007
Review of antibiotic resistance in China and its environment
2017 Standout
Optimizing clarithromycin-containing therapy forHelicobacter pyloriin the era of antibiotic resistance
2014
Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance
2014 Standout
Natural history of bleeding peptic ulcers with a tightly adherent blood clot: a prospective observation
1996
Helicobacter pylori: gastric cancer and beyond
2010
Optimized Nonbismuth Quadruple Therapies Cure Most Patients With Helicobacter pylori Infection in Populations With High Rates of Antibiotic Resistance
2013
A review of rescue regimens after clarithromycin-containing triple therapy failure (forHelicobacter pylorieradication)
2013
A risk score to predict need for treatment for uppergastrointestinal haemorrhage
2000 Standout
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
2012 Standout
Update on non-bismuth quadruple (concomitant) therapy for eradication of Helicobacter pylori
2012
Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms
2013 Standout
Efficacy of 5-Day Levofloxacin-Containing Concomitant Therapy in Eradication of Helicobacter pylori Infection
2012
Prevention of Hepatitis B reactivation in the setting of immunosuppression
2016
Lansoprazole‐based sequential and concomitant therapy for the first‐line Helicobacter pylori eradication
2012
Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis
2012
Practice Guidelines in Acute Pancreatitis
2006 Standout
Helicobacter pylori infection in functional dyspepsia
2013
Guidelines for treatment ofHelicobacter pyloriin the East and West
2011
Role of Albumin Treatment in Patients With Spontaneous Bacterial Peritonitis
2011
Differential inflammatory response to Helicobacter pylori infection: etiology and clinical outcomes
2015
Randomized controlled trial of carvedilol versus variceal band ligation for the prevention of the first variceal bleed # †
2009
Second Asia–Pacific Consensus Guidelines for Helicobacter pylori infection
2009
KDIGO Clinical Practice Guidelines for Acute Kidney Injury
2012 Standout
Portal Hypertensive Gastropathy
2002
Meta‐analysis: high‐dose proton pump inhibitors vs. standard dose in triple therapy for Helicobacter pylori eradication
2008
Standard triple and sequential therapies for Helicobacter pylori eradication: An update
2012
Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report
2006 Standout
Myeloperoxidase G-463A polymorphism and the risk of gastric cancer: a case-control study
2006
Continuous Infusion of Pantoprazole versus Ranitidine for Prevention of Ulcer Rebleeding: A U.S. Multicenter Randomized, Double-Blind Study
2006
Glycosylation in cancer: mechanisms and clinical implications
2015 Standout
14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial
2011
American College of Gastroenterology Guideline on the Management of Helicobacter pylori Infection
2007
Pilot Studies to Identify the Optimum Duration of Concomitant Helicobacter pylori Eradication Therapy in Thailand
2012
The pros, cons, and many unknowns of probiotics
2019 Standout
An Update of The Cochrane Systematic Review of Helicobacter Pylori Eradication Therapy in Nonulcer Dyspepsia: Resolving The Discrepancy Between Systematic Reviews
2003
Helicobacter pylori induces β3GnT5 in human gastric cell lines, modulating expression of the SabA ligand sialyl–Lewis x
2008
Prevention and Management of Gastroesophageal Varices and Variceal Hemorrhage in Cirrhosis
2007
Guidelines for the Management of Helicobacter pylori Infection in Japan: 2009 Revised Edition
2010
The human microbiome: at the interface of health and disease
2012 Standout
Successful outpatient management of acute upper gastrointestinal hemorrhage: use of practice guidelines in a large patient series
1998
Endoscopic clipping for acute nonvariceal upper-GI bleeding: a meta-analysis and critical appraisal of randomized controlled trials
2008
Meta‐analysis: isosorbide‐mononitrate alone or with either beta‐blockers or endoscopic therapy for the management of oesophageal varices
2010
Hepatitis B Virus Reactivation and Prophylaxis During Solid Tumor Chemotherapy
2015
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Interleukin-1B Polymorphisms and Gastric Cancer Risk—A Meta-analysis
2006
Ten‐day sequential versus triple therapy for H elicobacter pylori eradication: A prospective, open‐label, randomized trial
2012
International Consensus Recommendations on the Management of Patients With Nonvariceal Upper Gastrointestinal Bleeding
2010 Standout
The Efficacy of Moxifloxacin-Containing Triple Therapy after Standard Triple, Sequential, or Concomitant Therapy Failure for Helicobacter pylori Eradication in Korea
2014
homB Status of Helicobacter pylori as a Novel Marker To Distinguish Gastric Cancer from Duodenal Ulcer
2009
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
2017 Standout
Reverse Sequential Therapy Achieves a Similar Eradication Rate as Standard Sequential Therapy for H elicobacter pylori Eradication: A Randomized Controlled Trial
2014
Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1)
2013 Standout
Band ligation versus no intervention for primary prevention of upper gastrointestinal bleeding in adults with cirrhosis and oesophageal varices
2019
Helicobacter pyloriand Gastric Cancer: Factors That Modulate Disease Risk
2010
The Efficacy of Second‐Line Anti‐Helicobacter pylori Therapy Using an Extended 14‐Day Levofloxacin/Amoxicillin/Proton‐Pump Inhibitor Treatment – A Pilot Study
2012
Appropriate First-Line Regimens to Combat Helicobacter pylori Antibiotic Resistance: An Asian Perspective
2015
Tailored versus Triple plus Bismuth or Concomitant Therapy as Initial Helicobacter pylori Treatment: A Randomized Trial
2015
Epinephrine injection versus epinephrine injection and a second endoscopic method in high-risk bleeding ulcers
2014
New Strategies for Fluorescent Probe Design in Medical Diagnostic Imaging
2009 Standout
Endoscopic Band Ligation Versus Pharmacological Therapy for Variceal Bleeding in Cirrhosis: A Meta-Analysis
2011
Helicobacter pylori Eradication and Gastric Cancer: When Is the Horse Out of the Barn?
2009
Ten day sequential versus 10 day modified bismuth quadruple therapy as empirical firstline and secondline treatment for Helicobacter pylori in Chinese patients: an open label, randomised, crossover trial
2013
Chemotherapy for advanced gastric cancer
2017 Standout
Comparison of Hybrid and Sequential Therapies for H elicobacter pylori Eradication in I ran: A Prospective Randomized Trial
2012
ICOS+Foxp3+TILs in gastric cancer are prognostic markers and effector regulatory T cells associated withHelicobacter pylori
2016 StandoutNobel
Consensus Recommendations for Managing Patients with Nonvariceal Upper Gastrointestinal Bleeding
2003
Role of Intravenous Omeprazole in Patients with High-Risk Peptic Ulcer Bleeding After Successful Endoscopic Epinephrine Injection: A Prospective Randomized Comparative Trial
2006
Pathogenesis ofHelicobacter pyloriInfection
2006 Standout
Meta-Analysis of Sequential, Concomitant and Hybrid Therapy for <i>Helicobacter pylori</i> Eradication
2015
Clinical Outcomes of Two‐Week Sequential and Concomitant Therapies for Helicobacter pylori Eradication: A Randomized Pilot Study
2013
Seven-Day Nonbismuth Containing Quadruple Therapy Could Achieve a Grade “A” Success Rate for First-LineHelicobacter pyloriEradication
2015
Primary antibiotic resistance ofHelicobacter pyloristrains isolated from patients with dyspeptic symptoms in Beijing: A prospective serial study
2015
Global Epidemiology of Campylobacter Infection
2015 Standout
Secondary prevention of variceal bleeding in adults with previous oesophageal variceal bleeding due to decompensated liver cirrhosis: a network meta-analysis
2021
Oxidative Stress: An Essential Factor in the Pathogenesis of Gastrointestinal Mucosal Diseases
2014 Standout
Clinical Evaluation of a Ten‐Day Regimen with E someprazole, M etronidazole, A moxicillin, and C larithromycin for the Eradication of H elicobacter pylori in a High Clarithromycin Resistance Area
2013
The efficacy of hybrid therapy as first‐line regimen for H elicobacter pylori infection compared with sequential therapy
2014
Helicobacter pylori and gastric adenocarcinoma
2009
Prevalence of portal hypertensive duodenopathy in cirrhosis: clinical and haemodynamic features
2006
Obesity and chronic kidney disease
2022
Modified Sequential Therapy Regimen versus Conventional Triple Therapy forHelicobacter pyloriEradication in Duodenal Ulcer Patients in China: A Multicenter Clinical Comparative Study
2012
Systematic review with meta‐analysis: post‐infectious functional dyspepsia
2014
First-line eradication rates comparing two shortened non-bismuth quadruple regimens againstHelicobacter pylori: an open-label, randomized, multicentre clinical trial
2015
Feasibility of Shortening 14‐day Hybrid Therapy While Maintaining an Excellent Helicobacter pylori Eradication Rate
2014
Sequential, concomitant and hybrid first-line therapies for Helicobacter pylori eradication: a prospective randomized study
2014
Rebleeding prophylaxis improves outcomes in patients with hepatocellular carcinoma. A multicenter case-control study
2013
Eradication of Helicobacter pylori for non-ulcer dyspepsia
2011
Hybrid Therapy as First‐Line Regimen for Helicobacter pylori Eradication in Populations with High Antibiotic Resistance Rates
2016
Primary prevention of variceal bleeding in people with oesophageal varices due to liver cirrhosis: a network meta-analysis
2021
Proton Pump Inhibitor Therapy for Peptic Ulcer Bleeding: Cochrane Collaboration Meta-analysis of Randomized Controlled Trials
2007
Concomitant and hybrid therapy for H elicobacter pylori infection: A randomized clinical trial
2015
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
Sequential versus standard triple first-line therapy forHelicobacter pylorieradication
2016
Lactobacillus -containing probiotic supplementation increases Helicobacter pylori eradication rate: evidence from a meta-analysis
2013
Sequential or concomitant therapy for eradication of H elicobacter pylori infection: A systematic review and meta‐analysis
2015
Review: Efficacy and Safety of Hybrid Therapy for Helicobacter pylori Infection: A Systematic Review and Meta‐analysis
2014
Works of Ping‐I Hsu being referenced
Upregulation of CCL20 and Recruitment of CCR6+Gastric Infiltrating Lymphocytes inHelicobacter pyloriGastritis
2007
Bleeding peptic ulcer--risk factors for rebleeding and sequential changes in endoscopic findings.
1994
Fecal microbiota transplantation: Review and update
2018
The effects of endoscopic variceal ligation and propranolol on portal hypertensive gastropathy: A prospective, controlled trial
2001
Endoscopic ligation vs. nadolol in the prevention of first variceal bleeding in patients with cirrhosis
2004
Banding ligation versus nadolol and isosorbide mononitrate for the prevention of esophageal variceal rebleeding
2002
Sequential and Concomitant Therapy With Four Drugs Is Equally Effective for Eradication of H pylori Infection
2009
A Randomized Controlled Study Comparing Reverse Hybrid Therapy and Standard Triple Therapy for Helicobacter pylori Infection
2015
High‐dose versus low‐dose esomeprazole‐based triple therapy for Helicobacter pylori infection
2007
Rabeprazole‐ versus Esomeprazole‐Based Eradication Regimens for H. pylori Infection
2007
Comparison of hemostatic efficacy for epinephrine injection alone and injection combined with hemoclip therapy in treating high-risk bleeding ulcers
2006
Quadruple rescue therapy for Helicobacter pylori infection after two treatment failures
2008
A Prospective Randomized Trial of Esomeprazole- versus Pantoprazole-Based Triple Therapy for Helicobacter pylori Eradication
2005
Risks of interleukin‐1 genetic polymorphisms and Helicobacter pylori infection in the development of gastric cancer
2004
Does cholecystectomy after endoscopic sphincterotomy prevent the recurrence of biliary complications?
1999
Randomized comparison of two rescue therapies for Helicobacter pylori infection
2006
The additive effect of sclerotherapy to patients receiving repeated endoscopic variceal ligation: A prospective, randomized trial
1998
Effect of intravenous albumin on endotoxin removal, cytokines, and nitric oxide production in patients with cirrhosis and spontaneous bacterial peritonitis
2009
Improved survival in patients receiving medical therapy as compared with banding ligation for the prevention of esophageal variceal rebleeding†
2008
Prophylactic banding ligation of high-risk esophageal varices in patients with cirrhosis: a prospective, randomized trial
1999
Endoscopic 13C-urea breath test for the diagnosis of Helicobacter pylori infection
2003
Intravenous pantoprazole versus ranitidine for prevention of rebleeding after endoscopic hemostasis of bleeding peptic ulcers
2004
The effects of eradication of Helicobacter pylori on the recurrence of duodenal ulcers in patients with cirrhosis
2005
A 15‐minute [13C]‐urea breath test for the diagnosis of Helicobacter pylori infection in patients with non‐ulcer dyspepsia
2000
Association of themyeloperoxidase-468G→A polymorphism with gastric inflammation and duodenal ulcer risk
2005
Comparison of 10 day bismuth quadruple therapy with high-dose metronidazole or levofloxacin for second-line Helicobacter pylori therapy: a randomized controlled trial
2012
Duodenal ulcer promoting gene of Helicobacter pylori
2005
Establishment of red fluorescent protein-tagged HeLa tumor metastasis models: Determination of DsRed2 insertion effects and comparison of metastatic patterns after subcutaneous, intraperitoneal, or intravenous injection
2003
Modified Sequential Helicobacter pylori Therapy: Proton Pump Inhibitor and Amoxicillin for 14 Days with Clarithromycin and Metronidazole added as a Quadruple (Hybrid) Therapy for the Final 7 Days
2011
Helicobacter pylori Infection and the Risk of Gastric Malignancy
2007
Sequential therapy achieves a higher eradication rate than standard triple therapy in Taiwan
2011
Randomized Comparison of Two Nonbismuth-Containing Rescue Therapies for Helicobacter pylori
2011
Eradication of Helicobacter pylori prevents ulcer development in patients with ulcer‐like functional dyspepsia
2001
A Comparison of Entecavir and Lamivudine for the Prophylaxis of Hepatitis B Virus Reactivation in Solid Tumor Patients Undergoing Systemic Cytotoxic Chemotherapy
2015
Randomized Controlled Trial Comparing 7-Day Triple, 10-Day Sequential, and 7-Day Concomitant Therapies for Helicobacter pylori Infection
2014
Comparison of cetraxate-based and pantoprazole-based triple therapies in the treatment of Helicobacter pylori infection.
2004
Comparison of Endoscopic Variceal Ligation and Nadolol Plus Isosorbide-5-mononitrate in the Prevention of First Variceal Bleeding in Cirrhotic Patients
2006
Enhanced Proliferation and Increased IFN-γ Production in T Cells by Signal Transduced Through TNF-Related Apoptosis-Inducing Ligand
2001
Ten‐Day Quadruple Therapy Comprising Proton‐Pump Inhibitor, Bismuth, Tetracycline, and Levofloxacin Achieves a High Eradication Rate for H elicobacter pylori Infection after Failure of Sequential Therapy
2013
A prospective, randomized trial of endoscopic hemoclip placement and distilled water injection for treatment of high-risk bleeding ulcers
2003